Diametric Capital’s Phibro Animal Health PAHC Stock Holding History

Diametric Capital’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,513	Closed	-$281K	–	556
2025 Q4	$281K	Buy	+7,513	New	+$305K	0.08%	309

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Diametric Capital's PAHC Position: Q1 2026 in Review

Diametric Capital sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 7,513 shares — an estimated $281K sold.

Diametric Capital first reported a position in PAHC in Q4 2025 and held it in 1 quarter. The position peaked at $281K in Q4 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

Diametric Capital reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
Diametric Capital sold 7,513 Phibro Animal Health shares in Q1 2026, an estimated $281K.
Diametric Capital first reported a position in Phibro Animal Health in Q4 2025 and held it in 1 quarter.
Diametric Capital's Phibro Animal Health position peaked at $281K in Q4 2025.
257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.